Skip to content

Medium-term Effects of Passive Skeletal Muscle Motion due to Electrical Stimulation on Blood Sugar Control in Diabetic Patients

Medium-term Effects of Passive Skeletal Muscle Motion due to Electrical Stimulation on Blood Sugar Control in Diabetic Patients - Lower limb electrical stimulation therapy in diabetic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000009413
Enrollment
20
Registered
2012-11-27
Start date
2012-12-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Intervention groups (2 groups: preprandial intervention group and postprandial intervention group) Electrical stimulation was conducted at &gt
3 hours after breakfast or lunch in the preprandial intervention group, while electrical stimulation was conducted from 30 minutes to 2 hours after breakfast or lunch in the postprandial intervention

Sponsors

Tsukuba University School of Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: HbA1c (NGSP) was 7.0-9.0%, and the rate of change for the previous 16 weeks was <1%. Both daily activities and walking were autonomous. Age: 20 to 69 years

Exclusion criteria

Exclusion criteria: Patients with diabetic complications Proliferative retinopathy (excluding patients who were in a stable condition after photocoagulation therapy) Stage 3B or more advanced stages of diabetic nephropathy Patients with painful neuropathy NYHA-2 or more advanced stages, or patients with chronic cardiac insufficiency who used pacemakers Patients with malignant tumor and undergoing medical treatments, including chemotherapy or radiation therapy (excluding past illness) Patients receiving adrenocortical hormone Patients undergoing medical treatment for Cushings syndrome or acromegaly Postgastrectomy patients Patients with gait disturbance in the hip or knee joint (non-autonomous walking) as a motor impairment Patients with paralysis (including incomplete paralysis) due to diseases of the central nervous system Patients with cognitive disturbance (unable to communicate) and those unable to understand instructions

Design outcomes

Primary

MeasureTime frame
The change in HbA1c

Secondary

MeasureTime frame
Weight, BMI, skeletal muscle volume, somatic fat volume, knee extension muscular strength, knee extension stamina. The change in HbA1c due to preprandial and postprandial interventions, blood sugar level, insulin (IRI), C-peptide in blood (CPR), total cholesterol (T-Cho), LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), neutral fat (TG), cholinesterase (ChE) (Measured while the target patients were hungry. HOMA-R and HOMA-b were calculated from fasting blood sugar level and IRI). Fatty acid compartmentation out of all lipids, glycoalbumin in blood, 1.5-AG. Blood sugar level in the glucose tolerance test, IRI, RG, CPR (area under the curve).

Countries

Japan

Contacts

Public ContactYasuhiro Suzuki

Tsukuba University School of Hospital Department of rehabilitation

029-853-3795

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026